Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
RedPath Integrated Pathology, Inc [Member]
Stock Issued During Period, Shares, Treasury Stock Reissued 0            
Stock Issued During Period, Value, Treasury Stock Reissued $ 0            
Beginning Balance, shares at Dec. 31, 2013   16,316,000 1,146,000        
Beginning Balance at Dec. 31, 2013   $ 163 $ (14,106) $ 130,229 $ (83,823) $ 16  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, shares   81,000          
Common stock issued 0 $ 0   0      
Adjustments to Additional Paid in Capital, Other             $ 1,820
SARs exercised, shares   0          
SARs exercised   $ 0          
Restricted stock issued, shares   174,000          
Restricted stock issued   $ (2)   (2)      
Restricted stock forfeited, shares   (13,000)          
Restricted stock forfeited   $ 0          
Treasury stock purchased, shares     51,000        
Treasury stock purchased     $ (228)        
Stock-based compensation expense       2,124      
Net loss (16,073)       (16,073)    
Unrealized holding loss on available-for-sale securities, net of tax 0         0  
Ending Balance, shares at Dec. 31, 2014   16,558,000 1,197,000        
Ending Balance at Dec. 31, 2014 $ 20,122 $ 165 $ (14,334) 134,171 (99,896) 16  
Stock Issued During Period, Shares, Treasury Stock Reissued (500,000)            
Stock Issued During Period, Value, Treasury Stock Reissued $ (6,110)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, shares   1,321,000          
Common stock issued $ 2 $ 13   451      
Adjustments to Additional Paid in Capital, Other             $ 0
SARs exercised, shares 0 0          
Restricted stock issued, shares 1,343,178 874,000          
Restricted stock issued $ 0 $ (9)   (9)      
Restricted stock forfeited, shares (690,581) (48,000)          
Restricted stock forfeited   $ 0          
Treasury stock purchased, shares     346,000        
Treasury stock purchased     $ (208)        
Stock-based compensation expense       4,017      
Net loss $ (11,356)       (11,356)    
Unrealized holding loss on available-for-sale securities, net of tax (3)         (3)  
Ending Balance, shares at Dec. 31, 2015   18,705,000 1,043,000        
Ending Balance at Dec. 31, 2015 $ 13,038 $ 187 $ (8,432) $ 132,522 $ (111,252) $ 13